What is Finacea

Finacea® 15% Gel (azelaic acid) is a topical prescription-only treatment for mild to moderate acne vulgaris. It works by unblocking pores, reducing blackheads and whiteheads, and targeting acne-causing bacteria (Propionibacterium acnes), which helps calm inflammation and improve skin clarity. Visible improvement is usually seen after 4–8 weeks of consistent use.

Who is Finacea for

Finacea® is intended for individuals aged 12 years and above who meet specific criteria:

1. Confirmed acne diagnosis For those presenting with mild to moderate acne vulgaris, as defined by NICE guidelines, any number of comedones, up to 34 inflammatory lesions, and up to 2 nodules.
2. No complicating skin conditions Not suitable for patients with severe acne or complicating dermatological conditions (e.g. rosacea, acne conglobata, acne fulminans, or perioral dermatitis).
3. Preference for private access For those who wish to access acne treatment through a pharmacist-led consultation rather than a GP appointment.

Consultation process

Your treatment will be supplied under a Patient Group Direction (PGD), not a traditional prescription. The process includes the following steps:

1. Complete an online health questionnaire

Provide information about your acne symptoms, medical history, and previous treatments.

2. Pharmacist assessment

A pharmacist authorised under this PGD will review your responses and may contact you by phone or video call to confirm eligibility.

3. Private consultation

All consultations are confidential, allowing you to ask questions and confirm that Finacea® 15% Gel is suitable for you.

4. All-inclusive pricing

The consultation fee is included in the total price. No hidden costs.

5. Identity verification

First-time patients will be asked to verify their identity to ensure safe and appropriate supply.

6. GP or record consent if required

If clarification is needed, consent to contact your GP or review your medical records may be requested.

Purchasing this medication does not guarantee supply. Final suitability will be determined during the pharmacist consultation under the PGD. If deemed unsuitable, your order will be refunded.

For patients with uncertain diagnosis, severe acne, or acne leading to scarring or pigmentary changes, referral to a GP or specialist is advised.

Patient Information Leaflet

Active ingredient: Azelaic acid 15% (150 mg per gram of gel)

Other ingredients:

• Benzoic acid (E210)
• Carbomers
• Disodium edetate
• Lecithin
• Polysorbate 80
• Propylene glycol
• Purified water
• Sodium hydroxide
• Medium-chain triglycerides

1. Cleanse the skin gently and pat dry.
2. Apply a thin layer of Finacea Gel twice daily (morning and evening).
3. Use about 2.5 cm (0.5 g) of gel, enough for the whole face.
4. Wash hands after application.

Patients with sensitive skin should use this products only once a day (in the evening) for the first week of treatment and then proceed to twice-daily applications.

The duration of treatment varies, but noticeable improvement usually occurs within 4 weeks. For optimal results, the cream should be used continuously over several months, but should not exceed 12 months of use.

Follow the Patient Information Leaflet for further information regarding the application.

• May cause mild skin irritation, burning, or redness during the first weeks of treatment. If irritation occurs, reduce application frequency or pause use temporarily.
• Do not combine with other topical acne treatments unless advised by a healthcare professional.

Contraindications

• Known hypersensitivity to azelaic acid or any excipients in the formulation.
• Under 12 years of age.
• Pregnancy or breastfeeding unless specifically recommended by a healthcare professional.
• Presence of rosacea, perioral dermatitis, or other inflammatory skin conditions.
• Severe acne (e.g. acne conglobata or acne fulminans).
• Application to sunburned, irritated, or recently treated skin (chemical peels, laser, or similar procedures).
• Avoid contact with eyes, mouth, and mucous membranes.

Common reactions are mild and often improve with continued use:

• Burning, stinging, or itching at the application site
• Redness, dryness, or rash
• Rarely, swelling or worsening of asthma symptoms

Seek urgent medical attention if you experience facial swelling, difficulty breathing, or hives.

You can report side effects via the MHRA Yellow Card Scheme at www.mhra.gov.uk/yellowcard.